These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7134889)
1. Degradation of soluble immunoglobulin aggregates in vitro by monocytes from normal subjects and from patients with systemic lupus erythematosus. Daha MR; van ES LA; Hazevoet HM; Kijlstra A Scand J Immunol; 1982 Aug; 16(2):117-22. PubMed ID: 7134889 [TBL] [Abstract][Full Text] [Related]
2. Fc- and complement receptor-dependent degradation of soluble immune complexes and stable immunoglobulin aggregates by guinea pig monocytes, peritoneal macrophages, and Kupffer cells. Daha MR; van Es LA J Leukoc Biol; 1984 Nov; 36(5):569-79. PubMed ID: 6593389 [TBL] [Abstract][Full Text] [Related]
3. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages. Daha MR; Van Es LA Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062 [TBL] [Abstract][Full Text] [Related]
4. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages. Daha MR; van Es LA Immunology; 1982 Sep; 47(1):203-9. PubMed ID: 7118161 [TBL] [Abstract][Full Text] [Related]
5. Diminished uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis and vasculitis. Daha MR; Westedt ML; Bos B; Krol MC; van Es LA; Cats A J Rheumatol; 1987 Aug; 14(4):680-5. PubMed ID: 3668974 [TBL] [Abstract][Full Text] [Related]
6. Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages. Daha MR; Van Es LA Immunology; 1983 Sep; 50(1):107-11. PubMed ID: 6224740 [TBL] [Abstract][Full Text] [Related]
7. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells. Daha MR; Gorter A; Leijh PJ; Klar N; van Es LA Immunology; 1988 Jul; 64(3):375-9. PubMed ID: 2970428 [TBL] [Abstract][Full Text] [Related]
8. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus. Lobatto S; Daha MR; Breedveld FC; Pauwels EK; Evers-Schouten JH; Voetman AA; Cats A; Van Es LA Clin Exp Immunol; 1988 Apr; 72(1):55-9. PubMed ID: 3396221 [TBL] [Abstract][Full Text] [Related]
9. Uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis: relation to disease activity. Heurkens AH; Westedt ML; Breedveld FC; Jonges E; Cats A; Stijnen T; Daha MR Ann Rheum Dis; 1991 May; 50(5):284-9. PubMed ID: 2042981 [TBL] [Abstract][Full Text] [Related]
10. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679 [TBL] [Abstract][Full Text] [Related]
11. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA. Larsson A; Sjöquist J J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing the endocytosis of immune complexes. van Es LA; Daha MR Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677 [TBL] [Abstract][Full Text] [Related]
13. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus. Daha MR; Hazevoet HM; Vanes LA Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604 [TBL] [Abstract][Full Text] [Related]
14. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera. Håkansson L; Hällgren R; Venge P Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589 [TBL] [Abstract][Full Text] [Related]
15. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice. Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230 [TBL] [Abstract][Full Text] [Related]
16. Elimination of soluble 123I-labelled aggregates of human immunoglobulin G in humans; the effect of splenectomy. Halma C; Daha MR; van Furth R; Camps JA; Evers-Schouten JH; Pauwels EK; Lobatto S; Van Es LA Clin Exp Immunol; 1989 Jul; 77(1):62-6. PubMed ID: 2788541 [TBL] [Abstract][Full Text] [Related]
17. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583 [TBL] [Abstract][Full Text] [Related]
18. Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement. Schifferli JA Immunol Lett; 1985; 9(5):297-9. PubMed ID: 3997205 [TBL] [Abstract][Full Text] [Related]
19. Enhanced Fc receptor function of monocytes from patients with clinically active systemic lupus erythematosus: binding and degradation of soluble immune complexes in vitro. Kabashima T; Sakurai T; Yamane K; Kono I; Kashiwagi H Jpn J Med; 1986 Aug; 25(3):263-9. PubMed ID: 3773319 [TBL] [Abstract][Full Text] [Related]
20. A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM. Zhuang H; Han S; Li Y; Kienhöfer D; Lee P; Shumyak S; Meyerholz R; Rosadzinski K; Rosner D; Chan A; Xu Y; Segal M; Sobel E; Yang LJ; Hoffmann MH; Reeves WH Arthritis Rheumatol; 2016 Dec; 68(12):2917-2928. PubMed ID: 27274010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]